Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Drug Safety Crisis Response My Core Decision I will recommend full, proactive disclosure. Waiting is not a viable option. Here's why: Every day of delay adds approximately 22 patients exposed to an undisclosed risk Regulatory agencies treat delayed voluntary disclosure far more favorably than…Read the full answer
As CEO, you disclose — immediately, voluntarily, and completely. There is no version of "wait for more data" that is ethical, legal, or even financially smart. Here's the math that makes the decision for you: 4,000,000 patients x 1/8,000 risk over 5 years = ~500 cases of liver failure.Read the full answer